Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke

Journal of Neuroinflammation

Volumn 13, Issue 1, 2016, Pages

  Zangari, R ^a,b   Zanier, E R ^a   Torgano, G ^c   Bersano, A ^d   Beretta, S ^e   Beghi, E ^b   Casolla, B ^f   Checcarelli, N ^g   Lanfranconi, S ^c   Maino, A ^c   Mandelli, C ^c   Micieli, G ^h   Orzi, F ^f   Picetti, E ⁱ   Silvestrini, M ^j   Stocchetti, N ^b   Zecca, B ^c   Garred, P ^k   De Simoni, M G ^a   Alberti, P ^e   Ferrarese, C ^e   Giopato, F ^e   Cavallini, A ^h   Denaro, F ^h   Lattanzi, S ^j   Munthe Fog, L ^k   Bianchi, E ^a   more..

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g VALDUCE HOSPITAL   (Italy)

^h C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

ⁱ UNIVERSITY HOSPITAL OF PARMA   (Italy)

^j UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

Ficolin 1; Ficolin 2; Ficolin 3; Innate immunity; Ischemic stroke; Lectin pathway; MBL

Indexed keywords

FICOLIN 1; FICOLIN 2; FICOLIN 3; MANNOSE BINDING LECTIN; MARKER; UNCLASSIFIED DRUG; FICOLIN; LECTIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; SENSITIVITY AND SPECIFICITY; STROKE PATIENT; AGE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; ITALY; MIDDLE AGED; NONPARAMETRIC TEST; REGRESSION ANALYSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTOR;

ADULT; AGE FACTORS; AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; ITALY; LECTINS; MALE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STROKE; TIME FACTORS;

EID: 84954427988     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-016-0481-2     Document Type: Article

References (38)

1. Füst G, Munthe-Fog L, Illes Z, Széplaki G, Molnar T, Pusch G, et al. Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke. J Neuroinflammation. 2011;8:185.
2. Zanier ER, Zangari R, Munthe-Fog L, Hein E, Zoerle T, Conte V, et al. Ficolin-3-mediated lectin complement pathway activation in patients with subarachnoid hemorrhage. Neurology. 2014;82:126-34.
3. Yongqing T, Drentin N, Duncan RC, Wijeyewickrema LC, Pike RN. Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions? Biochim Biophys Acta. 2012;1824:253-62.
4. Endo Y, Matsushita M, Fujita T. New insights into the role of ficolins in the lectin pathway of innate immunity. Int Rev Cell Mol Biol. 2015;316:49-110.
5. Honoré C, Rørvig S, Hummelshøj T, Skjoedt M-O, Borregaard N, Garred P. Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. J Leukoc Biol. 2010;88:145-58.
6. Rørvig S, Honore C, Larsson L-I, Ohlsson S, Pedersen CC, Jacobsen LC, et al. Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP. J Leukoc Biol. 2009;86:1439-49.
7. Munthe-Fog L, Hummelshoj T, Honoré C, Moller ME, Skjoedt MO, Palsgaard I, et al. Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation. Genes Immun. 2012;13:515-22.
8. Munthe-Fog L, Hummelshøj T, Hansen BE, Koch C, Madsen HO, Skjødt K, et al. The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol. 2007;65:383-92.
9. Munthe-Fog L, Hummelshøj T, Ma YJ, Hansen BE, Koch C, Madsen HO, et al. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol. 2008;45:2660-6.
10. Kawasaki N, Yokota Y, Kawasaki T. Differentiation of conglutination activity and sugar-binding activity of conglutinin after removal of NH2-terminal 54 amino acid residues by endogenous serine protease(s). Arch Biochem Biophys. 1993;305:533-40.
11. Axelgaard E, Jensen L, Dyrlund TF, Nielsen HJ, Enghild JJ, Thiel S, et al. Investigations on collectin liver 1. J Biol Chem. 2013;288:23407-20.
12. Ma YJ, Skjoedt M-O, Garred P. Collectin-11/MASP complex formation triggers activation of the lectin complement pathway-the fifth lectin pathway initiation complex. J Innate Immun. 2013;5:242-50.
13. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun. 2006;7:85-94.
14. Cervera A, Planas AM, Justicia C, Urra X, Jensenius JC, Torres F, et al. Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PloS One. 2010;5, e8433.
15. Osthoff M, Katan M, Fluri F, Schuetz P, Bingisser R, Kappos L, et al. Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PloS One. 2011;6, e21338.
16. Orsini F, De Blasio D, Zangari R, Zanier ER, De Simoni M-G. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front Cell Neurosci. 2014;8:380.
17. Orsini F, Villa P, Parrella S, Zangari R, Zanier ER, Gesuete R, et al. Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation. 2012;126:1484-94.
18. De la Rosa X, Cervera A, Kristoffersen AK, Valdés CP, Varma HM, Justicia C, et al. Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice. Stroke J Cereb Circ. 2014;45:1453-9.
19. Széplaki G, Szegedi R, Hirschberg K, Gombos T, Varga L, Karádi I, et al. Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes. Atherosclerosis. 2009;204:315-20.
20. Song F-Y, Wu M-H, Zhu L-H, Zhang Z-Q, Qi Q-D, Lou C-L. Elevated serum mannose-binding lectin levels are associated with poor outcome after acute ischemic stroke in patients with type 2 diabetes. Mol Neurobiol. 2015;52:1330-40.
21. Zhang Z-G, Wang C, Wang J, Zhang Z, Yang Y-L, Gao L, et al. Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke. Mol Neurobiol. 2015;51:230-9.
22. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988;41:105-14.
23. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke J Cereb Circ. 1989;20:864-70.
24. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke J Cereb Circ. 1993;24:35-41.
25. Hein E, Munthe-Fog L, Thiara AS, Fiane AE, Mollnes TE, Garred P. Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin complement pathway in vivo. Clin Exp Immunol. 2015;179:294-9.
26. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis Basel Switz. 2008;25:457-507.
27. Garred P, Madsen HO, Kurtzhals JA, Lamm LU, Thiel S, Hey AS, et al. Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenetics Off J Br Soc Histocompat Immunogenetics. 1992;19:403-12.
28. Zanier ER, Brandi G, Peri G, Longhi L, Zoerle T, Tettamanti M, et al. Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. Intensive Care Med. 2011;37:302-9.
29. Wang HE, Shapiro NI, Safford MM, Griffin R, Judd S, Rodgers JB, et al. High-sensitivity C-reactive protein and risk of sepsis. PloS One. 2013;8, e69232.
30. Zecca B, Mandelli C, Maino A, Casiraghi C, Bolla G, Consonni D, et al. A bioclinical pattern for the early diagnosis of cardioembolic stroke. Emerg Med Int. 2014;2014:242171.
31. Eisen DP, Dean MM, Boermeester MA, Fidler KJ, Gordon AC, Kronborg G, et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;47:510-6.
32. Whiteley W, Tian Y, Jickling GC. Blood biomarkers in stroke: research and clinical practice. Int J Stroke Off J Int Stroke Soc. 2012;7:435-9.
33. Liu Y, Endo Y, Iwaki D, Nakata M, Matsushita M, Wada I, Inoue K, Munakata M, Fujita T: Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol Baltim Md 1950. 2005;175:3150-6.
34. Honoré C, Rørvig S, Munthe-Fog L, Hummelshøj T, Madsen HO, Borregaard N, et al. The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Mol Immunol. 2008;45:2782-9.
35. Zhang J, Yang L, Ang Z, Yoong SL, Tran TTT, Anand GS, Tan NS, Ho B, Ding JL: Secreted M-ficolin anchors onto monocyte transmembrane G protein-coupled receptor 43 and cross talks with plasma C-reactive protein to mediate immune signaling and regulate host defense. J Immunol Baltim Md 1950. 2010;185:6899-910.
36. Wang Z-Y, Sun Z-R, Zhang L-M. The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk. Neurochem Res. 2014;39:248-53.
37. Hummelshoj T, Fog LM, Madsen HO, Sim RB, Garred P. Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol Immunol. 2008;45:1623-32.
38. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC. Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun. 2010;2:167-80.